By Catherine Eckford (European Pharmaceutical Review)2024-05-10T18:04:46
A study on spectroscopy challenges during biosimilar analysis has highlighted a novel observation with potential implications for quality control when detecting protein structures.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-05-12T07:43:00Z
Sponsored by Sartorius, By European Pharmaceutical Review
2026-03-27T15:37:00
Sponsored by IMA Pharma
2026-04-30T10:37:00
Sponsored by Shimadzu
2026-04-14T12:32:00
Sponsored by Thermo Fisher Scientific
2025-06-03T13:35:00
Sponsored by bioMérieux, By European Pharmaceutical Review
2025-07-16T11:00:00
Sponsored by USP
2025-10-08T07:00:00
Sponsored by Entegris
Site powered by Webvision Cloud